Alembic gets FDA OK for generic Optivar

Press enter to search
Close search
Open Menu

Alembic gets FDA OK for generic Optivar

By Sandra Levy - 03/26/2019
Alembic Pharmaceuticals has received the Food and Drug Administration’s approval for azelastine hydrochloride ophthalmic solution, 0.05%.

The product is the generic of Mylan’s Optivar.

Azelastine hydrochloride ophthalmic solution 0.05% is indicated for the treatment of itching of
the eye associated with allergic conjunctivitis.

The product had a market value of roughly $8.5 million for the 12 months ended December 2018, according to IQVIA.

RELATED TOPICS